Does microvascular dysfunction link obesity with insulin resistance and hypertension?

Area of Science:

• Cardiovascular Science
• Metabolic Disorders
• Public Health

Background:

• Obesity is a growing public health concern linked to numerous clinical disorders.
• Microvascular dysfunction is increasingly recognized as a key factor in obesity-related complications.
• Insulin resistance and hypertension are significant health issues associated with obesity.

Purpose of the Study:

• To explore the link between impaired microvascular function and obesity-associated insulin resistance and hypertension.
• To understand the mechanisms underlying obesity-associated microvascular dysfunction.
• To identify potential therapeutic targets for obesity-related metabolic and cardiovascular issues.

Main Methods:

• This perspective synthesizes current research on microvascular function in obesity.
• It examines cellular and systemic mechanisms contributing to endothelial dysfunction.
• The review considers endocrine, vasocrine, and neurogenic pathways involved.

Main Results:

• Obesity is characterized by generalized microvascular dysfunction, potentially preceding insulin resistance and hypertension.
• Cellular mechanisms shift towards vasoconstriction, with reduced nitric oxide and increased endothelin-1.
• Communicative pathways involve adipokines and sympathetic activity, contributing to integrated microvascular defects.

Conclusions:

• Impaired microvascular function is a critical link between obesity, insulin resistance, and hypertension.
• Obesity-associated microvascular dysfunction results from integrated endocrine, vasocrine, and neurogenic factors.
• Further research into these mechanisms can uncover novel therapeutic strategies.